SCHEMBL15532201

SCHEMBL15532201

CCn1c(=O)c(C(=O)O)cn(-c2ccc3c(c2)nnn3C)c1=O

nearest known ligand 0.48

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.48
CMA1 P23946 15/20 0.48
HPGD P15428 2/20 0.43
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15542542 0.82 CMA1 (0.66) CMA1
SCHEMBL16704114 0.82 CMA1 (0.64) CMA1ALDH1A1MAPT
SCHEMBL16736501 0.82 CMA1 (0.75) CMA1
SCHEMBL15532302 0.81 CMA1 (0.47) CMA1
SCHEMBL15544436 0.81 CMA1 (0.53) CMA1KDM4EALDH1A1MAPT
SCHEMBL17644424 0.81 HDAC1 (0.52) CMA1KDM4E
SCHEMBL15531941 0.80 CMA1 (0.54) CMA1HPGDKDM4EHSD17B10ALDH1A1
SCHEMBL15532103 0.80 CMA1 (0.46) CMA1
SCHEMBL15544051 0.79 CMA1 (0.56) CMA1
SCHEMBL16736657 0.79 CMA1 (0.77) CMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3045456-B1 BICYCLIC SUBSTITUTED URACILS AND THEIR USE Bayer Pharma AG (DE) 2017-10-25 EP disclosed
EP-3045456-A1 BICYCLIC SUBSTITUTED URACILS AND THEIR USE Bayer Pharma Aktiengesellschaft (DE) 2016-07-20 EP disclosed
EP-2847190-B1 BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF Bayer Pharma AG (DE) 2016-04-06 EP disclosed
EP-2847190-A1 BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2015-03-18 EP disclosed
WO-2013167495-A1 BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2013-11-14 WO disclosed